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hree-Dimensional Echocardiography
he Benefits of the Additional Dimension
oberto M. Lang, MD,* Victor Mor-Avi, PHD,* Lissa Sugeng, MD,* Petra S. Nieman, MD,†
avid J. Sahn, MD†
hicago, Illinois; and Portland, Oregon
Over the past 3 decades, echocardiography has become a major diagnostic tool in the arsenal
of clinical cardiology for real-time imaging of cardiac dynamics. More and more, cardiolo-
gists’ decisions are based on images created from ultrasound wave reflections. From the time
ultrasound imaging technology provided the first insight into the human heart, our diagnostic
capabilities have increased exponentially as a result of our growing knowledge and developing
technology. One of the most significant developments of the last decades was the introduction
of 3-dimensional (3D) imaging and its evolution from slow and labor-intense off-line
reconstruction to real-time volumetric imaging. While continuing its meteoric rise instigated
by constant technological refinements and continuing increase in computing power, this tool
is guaranteed to be integrated in routine clinical practice. The major proven advantage of this
technique is the improvement in the accuracy of the echocardiographic evaluation of cardiac
chamber volumes, which is achieved by eliminating the need for geometric modeling and the
errors caused by foreshortened views. Another benefit of 3D imaging is the realistic and
unique comprehensive views of cardiac valves and congenital abnormalities. In addition, 3D
imaging is extremely useful in the intraoperative and postoperative settings because it allows
immediate feedback on the effectiveness of surgical interventions. In this article, we review the
published reports that have provided the scientific basis for the clinical use of 3D ultrasound
imaging of the heart and discuss its potential future applications. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.04748:2053–69) © 2006 by the American College of Cardiology Foundation
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bignificant advances in ultrasound, such as the transition
rom M-mode to 2-dimensional (2D) imaging, coupled
ith the addition of pulsed- and continuous-wave Doppler
nd color flow, have established echocardiography as one of
he most clinically used diagnostic tools in daily cardiology
ractice. Although 2D echocardiography has impacted our
bility to diagnose valvular and ischemic heart disease, the
oncept of 3-dimensional (3D) imaging has been envisioned
y numerous investigators as a natural evolution of this
echnology. Initial efforts used echocardiography-gated 2D
cquisition techniques based on freehand imaging from
ultiple acoustic windows or a single acoustic window,
ecessitating spatial tracking using a spark gap method or
agnetic locators (1–7). This methodology resulted in
ire-frame or surface-rendered reconstructions of the ven-
ricular chambers, from which accurate calculations of
entricular volumes (3–5,7–9), mass (9–12), and ejection
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ccepted July 10, 2006.raction (EF) (3–5,7–9) could be obtained. In addition,
his approach provided a more in-depth understanding of
he saddle shape of the mitral valve apparatus and thus
edefined our diagnostic criteria for mitral valve prolapse
13). Continued efforts led to sequential data acquisition,
ated to echocardiography and respiration using either a
otational, fan-like, or parallel approach. From either a
ransthoracic or transesophageal fixed acoustic window,
D images collected at smaller increments enabled
olume-rendered 3D reconstructions of ventricular or
alvular structures with more anatomical detail and spa-
ial relationships in complex congenital heart disease, not
een with previous 3D images (14–16). Visualization of
olor flow jets in 3 dimensions was also achieved using
his technique (17,18).
Although it became readily apparent that 3D echocardi-
graphy provides more accurate and reliable measurements
f chamber size and function and improved delineation of
alvular and congenital abnormalities, the complex acquisi-
ion and lengthy data analysis have limited the use of 3D
chocardiography in daily clinical practice. To overcome
hese limitations, investigators and manufacturers teamed to
evelop faster imaging strategies coupled with on-line
endering, which could be used for quantification of cham-
er size and function. One of the first attempts at volumetric
maging used a sparse array matrix transducer (2.5 or 3.5
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3D Echocardiography November 21, 2006:2053–69Hz) containing 256 elements that were activated nonsi-
ultaneously to generate a 60°  60° pyramidal volume
ithin a single heartbeat. Images were displayed in 2
rthogonal (B-scan) and 2 to 3 parallel short-axis planes
19,20). This approach was advantageous for stress testing
21,22) and also resulted in accurate left ventricular (LV)
olumes and EF (23–25). Although the sparse array trans-
ucer was capable of generating on-line different cut-planes
rom a 3D volume, it was unable to display in real-time
endered 3D images. In addition, poor image quality, large
ransducer footprint, and the lack of portability hampered
he use of this system.
Significant advances in ultrasound, electronic, and com-
uter technology have thrust the field forward toward the
evelopment of a fully sampled matrix array transducer and
n-line 3D display of rendered images (Fig. 1), as well as
oftware for postprocessing and quantification. The ease of
ata acquisition, the ability to image the entire heart nearly
n real time, as well as the ability to focus on a specific
tructure in a single beat have brought 3D echocardiography
loser to routine clinical use (Fig. 2). Within several years of
ts inception, real-time 3D technology has sparked new
ndeavors in research and opened a glimpse into the future
f echocardiography.
Abbreviations and Acronyms
2D  2-dimensional
3D  3-dimensional
EF  ejection fraction
LV  left ventricle/ventricular
MRI  magnetic resonance imaging
TEE  transesophageal echocardiographyigure 1. The transition from 2-dimensional (2D) to 3-dimensional (3D) imagin
f the heart at a time (left), 3D imaging scans a pyramidal volume (right). RTLINICAL APPLICATIONS
ince the early 1990s, the usefulness of 3D echocardiogra-
hy has been shown in several areas, including: 1) direct
valuation of cardiac chamber volumes without the need for
eometric modeling and without the detrimental effects of
oreshortened views (26–41); 2) unique noninvasive realis-
ic views of cardiac valves (13,42–58) and congenital abnor-
alities (59–71), extremely helpful for showing a variety of
athologies (72) and assessing the effectiveness of surgical or
ercutaneous transcatheter interventions (63,73–82); 3) di-
ect 3D assessment of regional LV wall motion aimed at
bjective detection of ischemic heart disease at rest (37,83–
6) and during stress testing (21,87), as well as quantifica-
ion of systolic asynchrony to guide ventricular resynchro-
ization therapy (88–92); 4) 3D color Doppler imaging
ith volumetric quantification of regurgitant lesions
18,67,93,94), shunts (95), and cardiac output (96,97); and
) volumetric imaging and quantification of myocardial
erfusion (98–102). In some instances, the scientific evi-
ence seems strong enough to endorse the use of 3D
chocardiography as a new standard in the clinical assess-
ent of the heart (40,103–106).
hamber quantification. One of the main reasons for
equesting an echocardiogram in routine clinical practice is
he assessment of global and regional LV function. To date,
his assessment is predominantly performed using visual
nterpretation or “eye-balling” of dynamic ultrasound im-
ges of the beating heart, which requires adequate training
nd experience to accurately estimate LVEF and evaluate
all motion. However, the limitations of this subjective
nterpretation have been long recognized, and consequently
he use of quantitative techniques has been recommended.
hus, multiple methods of measuring LV size and functiong. Although 2D imaging is based on scanning a single cross-sectional plane
3D  real-time 3D echocardiography.
h
M
r
r
1
b
v
t
i
m
f
t
a
T
b
v
r
a
o
t
t
p
E
2
e
a
p
l
(
h
u
s
s
p
f
F nsduc
w l. (32
F
t
2055JACC Vol. 48, No. 10, 2006 Lang et al.
November 21, 2006:2053–69 3D Echocardiographyave been developed, validated, and refined for both
-mode and 2D B-mode images, and subsequently for
econstructed 3D images and more recently for volumetric
eal-time 3D data sets. The relative inaccuracy of the
-dimensional and 2D echocardiographic approaches has
een attributed to the need for geometric modeling of the
entricle. The “missing dimensions” have also been consis-
ently referred to as the main source of the relatively wide
ntermeasurement variability of the echocardiographic esti-
ates of ventricular size and function. In addition, the
requently encountered limitations in endocardial visualiza-
ion, particularly in the apical-lateral segments of the LV,
re commonly compensated for by tilting the transducer.
his maneuver generally improves endocardial visualization,
ut at the same time generates oblique or foreshortened
iews of the ventricle, resulting in even less accurate and
eproducible measurements. In this regard, the biggest
dvantage of 3D echocardiography is the lack of dependence
igure 2. Different modes of data acquisition using the matrix-array tra
ide-angled scan (right). Reproduced, with permission, from Sugeng et aigure 3. Dynamic analysis of real-time 3-dimensional data. Biplanar display (l
ime point (middle), which allows the calculation of LV volume over time thron geometric modeling and image plane positioning, which
heoretically should result in accurate chamber quantifica-
ion (Fig. 3).
Nevertheless, almost all studies that have directly com-
ared the accuracy of 3D measurements of LV volumes and
F have shown the superiority of the 3D approach over the
D methodology, which was shown to consistently under-
stimate LV volumes. This superiority was shown in both
ccuracy and reproducibility when compared against inde-
endent reference techniques, such as radionuclide ventricu-
ography or magnetic resonance imaging (MRI)
3,4,12,21,30,34,35,40,107–110). These improvements
ave been shown irrespective of the 3D acquisition strategy
sed. Although in earlier 3D studies, quantification of LV
ize and function relied on tedious, manual, or at best
emiautomated tracing of endocardial boundaries in multi-
le planes, today it is based on near fully automated
rame-by-frame detection of the 3D endocardial surface
er. These include narrow-angled scan (left), zoom mode (middle), and
).eft) can be used to detect left ventricular (LV) endocardial surface at each
ughout the cardiac cycle (right).
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3D Echocardiography November 21, 2006:2053–69rom real-time 3D data sets. Recently, a similar approach
as implemented in commercial imaging systems, is rapidly
aining widespread popularity because of its accuracy and
ase of use (111), and is poised to become part of the
ainstream assessment of LV function.
Another clinically important variable that is frequently
ssessed by echocardiography is LV mass. Measurement of
V mass relies not only on endocardial but also on epicar-
ial visualization, which is known to be even more chal-
enging because of the difficulties in identifying the epicar-
ial border. This difficulty is in addition to the limitations
reviously discussed for the measurements of LV volumes,
uch as inaccurate modeling and foreshortening. Again, the
igure 4. Effects of volumetric imaging on the accuracy of left ventricular
LV) mass measurements. End-diastolic apical 4- (A4C) and 2-chamber
A2C) views of the LV obtained in a patient using conventional
-dimensional (2D) imaging (top) and anatomically correct apical 4- and
-chamber cut planes selected from a real-time 3-dimensional (3D) data
et obtained in the same subject (middle). Manually traced endocardial and
picardial boundaries used to calculate LV mass are shown on the images.
he LV long-axis dimension was measured on such images in 19 patients
bottom). Note the increase in the length of the LV in both apical views,
s assessed by the 3D technique in most patients (large circles and error
ars represent mean SD, *p 0.05). Reproduced, with permission, from
or-Avi et al. (114).se of 3D images seems to have overcome these limitations, ts several studies have reported significant improvements in
he accuracy and reproducibility of 3D estimates of LV mass
ompared with their traditional M-mode and 2D counter-
arts (10,11,106,112–115) (Fig. 4).
Similar results confirming improved accuracy and repro-
ucibility of the 3D approach were reported by investigators
ho compared 2D and 3D echocardiographic measure-
ents of left and right atrial volumes against an indepen-
ent gold standard (3,39,116,117). These findings may have
mportant clinical implications on the diagnosis and man-
gement of patients with atrial fibrillation, diastolic dys-
unction, and acute myocardial infarction.
Because of its complex geometrical crescent shape, the
stimation of right ventricular volumes based on geometric
odeling from 2D images has been extremely challenging.
hus, not surprisingly, the intrinsic ability of 3D imaging to
irectly measure right ventricular volumes without the need
or geometrical modeling has resulted in significant im-
rovements in accuracy and reproducibility compared with
reviously used 2D techniques (26,31,118–120).
Diagnosis of regional wall motion abnormalities in echo-
ardiographic studies is routinely performed by visually
ntegrating regional endocardial motion and wall thickness.
he reproducibility of this interpretation is limited because
f its subjective nature, which is also extremely dependent
n the experience of the reader. This is of particular concern
n patients with suboptimal image quality that impedes
ndocardial visualization. Not only may endocardial seg-
ents that are poorly visualized be incorrectly interpreted as
aving abnormal wall motion, but also discrete areas of
ypokinesis may be missed because they are simply not
isualized in the standard imaging planes. It is not uncom-
on for an echocardiographer performing the test to
lightly change transducer orientation to “better see” a
pecific myocardial segment. Such maneuvers can make a
yocardial segment look like an area of hypokinesis, or
lternatively, can make an apparent wall motion abnormality
isappear, and thus affect the diagnostic accuracy of the test.
n this regard, volumetric imaging is different because the
D data set contains the complete dynamic information on
V chamber contraction and filling.
Importantly, such data sets are acquired virtually instan-
aneously, and any 2D view can be obtained from them
imply by cropping out or “peeling off” the rest of the
nformation. In addition, the function of any ventricular
all can be objectively assessed by measuring a variety of
all motion parameters (37) (Fig. 5). For these reasons, 3D
ata sets are extremely appealing for the evaluation of
egional LV function. Real-time 3D imaging has been
ecently used during dobutamine stress testing and found to
e feasible and useful for the detection of stress-induced
all motion abnormalities (121) (Fig. 6). Several other
tudies have explored the potential of quantitative evalua-
ion of regional LV function based on segmental analysis of
he dynamic 3D endocardial surface (37,83–86). The use of
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November 21, 2006:2053–69 3D Echocardiographyhis methodology in clinical practice requires further studies
o be performed in larger groups of patients.
A clinically useful byproduct of the 3D quantification
f regional LV wall motion is the ability to quantify the
emporal aspects of regional endocardial systolic contrac-
ion, which have been used for objective serial diagnosis
f LV systolic asynchrony as a guide for resynchroniza-
ion therapy (90,91), despite the relatively low temporal
esolution of real-time 3D imaging. The standard devi-
tion of the regional ejection times (interval between the
wave and peak systolic endocardial motion) has been
sed as an index of myocardial synchrony. This approach
as been used to assess the short- and long-term benefits
f biventricular pacing (Fig. 7). A recent study has shown
direct relationship between overall LV performance and
igure 5. Volumetric analysis of regional left ventricular (LV) function. E
t 3 different phases of the cardiac cycle, superimposed on a cross-section
odel: A2C, A3C, and A4C  apical 2-, 3-, and 4-chamber planes, resp
itral valve (top right). Shaded area is an example of an LV endocardial
egional volume and wall motion time curves and regional shortening fracti
ith coronary artery disease (CAD) (right) and hypokinesis in the lateral
RR  percent of electrocardiogram RR-interval; pst  posterior; sp ynchronicity (92). In this study, this approach has also ieen shown to be useful for identifying patients with
evere heart failure and asynchronous LV contraction
ho could theoretically benefit from resynchronization
herapy but would not be considered candidates based on
heir QRS duration (92). Also, real-time 3D intracardiac
maging has been successfully used to guide the position-
ng of pacing catheters during interventional electrophys-
ology (89).
Recently, it has become feasible to perform multiplanar
imultaneous tissue Doppler-based strain rate imaging using
matrix array transducer (Fig. 8). The clinical benefits of
his approach versus the existing single plane strain and
train rate imaging have yet to be determined.
ontrast-enhanced 3D echocardiography. The ability of
onventional contrast-enhanced echocardiographic imag-
le of LV endocardial surface detected from a 3-dimensional (3D) data set
g-axis plane (top left). Schematic representation of the 3D segmentation
ly; Ao  central point of the aortic annulus; MV  central point of the
e segment representing the midseptal (m-sp) wall. Below are examples of
SF) in 6 apical segments, obtained in a normal subject (left) and a patient
arrow). Ant  anterior; asp  anteroseptal; inf  inferior; lat  lateral;
.xamp
al lon
ective
surfac
on (Rng to provide accurate information on the extent and
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3D Echocardiography November 21, 2006:2053–69everity of either wall motion or perfusion abnormalities
s also limited by its 2D nature. Despite the obvious
ppeal of the 3D imaging in this context, its use in
umans has not been explored until recently. This is
ecause this approach relied on off-line reconstruction
rom multiple planes, significantly complicating volumet-
ic assessment of LV function. The feasibility of applying
igure 6. Off-line viewing of real-time 3-dimensional data obtained during
iews at different levels of the left ventricle (left). Example of such views ext
igure 7. Assessment of the improvement in synchrony of left ventricular
patient with LV dyssynchrony without (top) and with (bottom) biventr
ith segmentation and color coding according to regional time to end ejec
ote the changes in colors with pacing reflecting the effects of resynchroniz
nteroseptal; EF  ejection fraction; Inf  inferior; Lat  lateral; Post  postolumetric analysis to contrast-enhanced real-time 3D
ata sets obtained in patients with suboptimal image
uality was recently tested. This approach allows quan-
ification of global (122) as well as regional (123) LV
unction when used with selective dual triggering at end
ystole and end diastole to reduce the destructive effects
f ultrasound on contrast microbubbles (Fig. 9).
tamine stress test. These data sets can be used to extract multiple short-axis
from data sets obtained at rest and during peak dobutamine stress (right).
contraction with pacing. Regional volume time curves (left) obtained in
pacing. Endocardial surfaces reconstructed from each data set are shown
middle) along with the bull’s-eye representation of the same data (right).dobu(LV)
icular
tion (ation therapy in this parametric display. Ant  anterior; Ant-Sept 
erior; Sept  septal.
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November 21, 2006:2053–69 3D EchocardiographyBefore the development of real-time 3D imaging, assess-
ent of myocardial perfusion had to remain limited to
ither visualization of perfusion defects (98) or at best
uantification of their size (99,100). Quantification of tissue
lood flow would require repeated contrast maneuvers, such
s bolus injections, which are necessary to assess flow
ynamics for each imaging plane, rendering this methodol-
gy clinically inapplicable. In contrast, real-time 3D echo-
ardiography offers an opportunity for online volumetric
maging of the entire heart during a single contrast-
nhancement maneuver. The feasibility of volumetric per-
usion imaging was recently tested (101,102) in conjunction
ith a new technique for volumetric quantitative analysis of
yocardial perfusion from contrast-enhanced real-time 3D
chocardiography data sets (102) (Fig. 10).
igure 8. Simultaneous multiplanar strain rate imaging. Matrix-array te
egments by analysis of tissue Doppler data obtained from the apical appr
igure 9. Real-time 3-dimensional (3D) visualization of myocardial perfu-
ion. Contrast-enhanced 3D data set obtained in a patient with severe discrete
eft anterior descending artery stenosis (left). A region in the interventricular
eptum shows lack of contrast enhancement, indicating a perfusion defect thatv
as supported by abnormal wall motion. This defect was visible in multiple
ross-sections (right), allowing easy estimation of its extent.The future uses of contrast enhancement for endocardial
urface delineation and volumetric myocardial perfusion
maging and quantification will be determined in larger
rials, which will also require expanded software capabilities.
alvular heart disease. Most studies using 3D echocardi-
graphy have focused on the evaluation of the mitral valve.
hese studies have played a crucial role in describing and
uantifying the geometry of the mitral annulus, leaflet
urface, tethering distances, and tenting volumes. These
tudies have also defined and quantified the relationship
etween the mitral apparatus and the position of the
apillary muscles, thus providing insight into the patho-
hysiology of mitral regurgitation.
Initially, 3D visualization of the mitral valve used a
ire-frame display, which was instrumental in describing
he saddle shape of the mitral annulus and redefining the
iagnostic criteria for mitral valve prolapse (13). A variety of
itral valve abnormalities have been shown by 3D recon-
tructions using gated transesophageal echocardiography
TEE) acquisition and volume-rendered display (124). The
ecent development of a fully sampled matrix array trans-
ucer has enabled real-time volumetric imaging of the
itral valve from the transthoracic approach (125) (Fig. 11,
op). The feasibility of this approach has been recently
emonstrated in a study that showed that the mitral valve
ould be adequately reconstructed in 70% of consecutive
atients (125). The anterior mitral valve leaflet was more
eadily visualized compared with the posterior leaflet, prob-
bly because of its larger size. The mitral leaflets, commis-
ures, and mitral valve orifice were also easily viewed. Of
ote, this study found that the posterior leaflet is best
ogy allows quantitative assessment of strain rate in multiple myocardialisualized from the parasternal window, whereas the ante-
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3D Echocardiography November 21, 2006:2053–69ior mitral leaflet was equally well seen from either the
arasternal or the apical window.
The utility of real-time 3D echocardiography in the
valuation of mitral stenosis and accuracy of mitral valve
rea measurements has been established by multiple studies
46,51,57,126–130). The main advantage of 3D echocardi-
graphy is the ability to achieve a perpendicular en-face cut
lane of the mitral valve orifice, enabling accurate mitral
alve area measurements. These measurements have been
igure 10. Volume rendering of the mitral valve obtained from real-time
erforated anterior mitral leaflet, which was confirmed by an intraoperativ
chocardiogr 2004;17:919–22.
igure 11. Real-time volumetric imaging and analysis of the mitral valve.
itral valve opening with bicommissural fusion. After valvuloplasty, splittin
xample of 3-dimensional reconstruction of the mitral annulus (C) and lea
hape of the annulus and increased leaflet tenting volume. IVS  interventric
osterior; RV  right ventricle.ound more accurate when performed from the ventricular
rientation. When compared with traditional 2D and
oppler measurements, such as 2D planimetry, pressure
alf-time, and flow convergence, 3D echocardiography best
greed with mitral orifice area calculations derived using the
orlin formula during cardiac catheterization (51,57,129).
mportantly, the 3D measurements had the additional
dvantage of having lower intraobserver and interobserver
ariability (51,57,129). The ease of acquisition and on-line
ensional data. The data set on the left was obtained in a patient with a
ge (right). Reproduced, with permission, from Schwalm et al. J Am Soc
Baseline image before mitral balloon valvuloplasty (A) shows a restricted
he medial commissure and posterior leaflet tear can be seen (B). (Bottom)
D) obtained in a patient with dilated cardiomyopathy, showing the saddle3-dim
e ima(Top)
g of t
flets (ular septum; LA  left atrium; LV  left ventricle; M  medial; P 
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November 21, 2006:2053–69 3D Echocardiographyeview of real-time 3D echocardiography facilitates imme-
iate assessment of the mitral valve commissural splitting,
tretching, or tearing after percutaneous balloon mitral
alvuloplasty (PBMV) in the cardiac catheterization labo-
atory. Immediately after PBMV, changes in left atrial and
entricular compliance together with irregularities of the
itral valve orifice limit the utility of the pressure half-time
ethod and 2D planimetry. The high accuracy and repro-
ucibility of 3D echocardiography before and after PBMV
ompared with the pressure half-time method and 2D
chocardiography have been shown in a recent article (130).
Characterization of the mitral valve apparatus using 3D
chocardiography (Fig. 11, bottom) has shed new light on
he pathophysiology of mitral regurgitation in patients with
onischemic and ischemic cardiomyopathy. It has been
hown that functional mitral regurgitation is associated with
nnular dilatation and reduced cyclic variations in annular
hape and area (52). Further investigations showed differ-
nces in patients with ischemic mitral regurgitation com-
ared with normal subjects in mitral annular shape with
ncreased intercommissural and anteroposterior diameters
nd increased leaflet tenting, indicating chordal tethering
28,47,58,131). Also, patients with anterior wall myocardial
nfarction have flattened mitral annulus, which is more
ronounced than with posterior myocardial infarction (132).
hree-dimensional echocardiography has also been used to
valuate the differences in the shape and dynamics of 2 types
f mitral rings: although the Duran ring seemed nonplanar
nd showed changes in annular area throughout the cardiac
ycle, the Carpentier ring was planar and did not effectively
hange its area (133).
Although the additional information provided by 3D
maging may aid in surgical planning and design of future
itral prostheses and rings, it has been recognized that
hanges in mitral annular deformation may not be the sole
ause of ischemic mitral regurgance (MR). Several studies
ave reported that MR caused by ischemia occurs in
onjunction with remodeling of the ischemic region, leading
o LV dilatation with subsequent papillary muscle displace-
ent (134,135). This results in increased chordal tethering
nd leaflet tenting, which in turn leads to mitral regurgita-
ion caused by decreased leaflet apposition. Interestingly, an
nimal 3D echocardiographic study showed that MR re-
olved after plication of the infarct region (135). Hence, the
nsights provided by 3D echocardiography have shown that
he presence of MR in patients with dilated or ischemic
ardiomyopathy is a disease of the remodeled myocardium
ather than being caused by a true valvular abnormality.
Compared with the mitral valve, the collective experience
n visualizing aortic valve disease is limited. Most of the
ortic valve imaging has been performed using gated 3D
cquisition from the transesophageal approach
43,48,55,94,136–141). The challenges with the 3D imag-
ng of the aortic valve are related to the fact that aortic
eaflets are thinner and frequently present with heavy
alcification, both resulting in drop-out artifacts. Neverthe- wess, it was found that adequate to excellent reconstruction
f the aortic valve is feasible in over 80% of patients, more
requently in native than in prosthetic valves (142). Similar
o mitral stenosis, in patients with aortic stenosis, TEE-
ased planimetry of the aortic valve is more accurate with
D than 2D imaging (48). Three-dimensional echocardi-
graphy also results in improved visualization and thus more
ccurate diagnosis of bicuspid aortic valves, valvular vegeta-
ion, prosthetic aortic valve leaks, and subaortic pathology.
owever, the additional information that 3D echocardiog-
aphy may offer in this context remains to be determined in
uture studies.
The utility of 3D echocardiography in the evaluation of
ricuspid valve disease has not been explored in depth.
here have been numerous case reports describing tricuspid
bnormalities such as tricuspid stenosis, cleft tricuspid valve,
nd a flail tricuspid leaflet (143–147). Initial observations
ade in the pediatric population, pertaining to the tricuspid
nnulus and its dynamic interaction with the mitral valve
nnulus, were that during systole, the area of the tricuspid
nnulus decreased more in lateral diameter compared with
he mitral annulus, and that the tricuspid annulus retained
ts shape more than the mitral annulus throughout systole
148). Characterization of the tricuspid annulus and leaflets
n patients with rheumatic heart disease with mitral stenosis
nd severe tricuspid regurgitation was performed using
ated 3D TEE, which showed thickened leaflets with
estricted motion, together with annular dilatation (149).
olumetric color Doppler imaging. Three-dimensional
olor flow imaging did not come to fruition until gated TEE
ethods and computer software allowed reconstruction of
D color flow jets superimposed on the reconstructed gray
cale data (Fig. 12). With the ability to combine 3D color
ow with gray scale information, it became possible to
etect the origin and direction of jets, to measure regurgi-
ant orifice areas, and to improve the delineation of valvular
eaks, paravalvular leaks, and multiple jets (18,94,150,151).
Initially, reconstructive 3D methods have been used to
btain 3D measurements of stroke volume using Doppler
elocities perpendicular to the outflow or inflow tracts
152,153). With this approach, the surface projection al-
owed removal of the known limitation of Doppler imaging
i.e., its angle dependency). Although acquisition times
ere still long, the time required for reconstruction was
ignificantly shortened. Multiple studies have been pub-
ished on the accuracy of this method by several investiga-
ors (154,155). Multiplanar TEE 3D color flow imaging,
owever, has many drawbacks because of the long time
equired for data acquisition, which may result in temporal
nd spatial misregistration. Another disadvantage is the
xtended time required for analysis, which has limited the
linical utility of this methodology.
Volumetric color flow imaging has overcome some of
hese limitations and proved useful for estimating regurgi-
ant volumes, stroke volumes, and cardiac output, together
ith the delineation of valve regurgitation in pediatric
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3D Echocardiography November 21, 2006:2053–69opulations (17,156–159). It has recently been shown that
D color Doppler imaging can provide accurate measure-
ents of flow in the great vessels and ventricles (Fig. 13) by
ampling the entire cross-sectional flow profile through the
entricular outflow tract, thus allowing the calculation of
alvular flow volume, regurgitant volume, fraction, and
rifice area (160). Although 3D Doppler laminar flow
easures were originally developed using reconstructive 3D,
eal-time color Doppler volumes are much less time consum-
ng; they reduce respiratory artifacts and allow immediate
eview without lengthy reconstruction (155). This approach
as initially validated in an in vitro setup and in open-chest
nimals (96,161), and more recently in humans (97).
However, there are several issues that continue hamper-
ng the daily use of 3D color flow imaging, including: 1)
eliance on acquisition of multiple cardiac cycles that may
esult in stitch artifacts because of the patient’s inability to
aintain a breath hold over 7 to 10 beats; 2) limited sector
ngle that may not allow complete visualization of eccentric
ets; and 3) compromised visualization of 3D gray-scale
nformation when acquired simultaneously with the color.
ingle-beat acquisition with wider sector and improved
esolution as well as online quantification tools are the issues
hat need to be addressed for 3D color flow imaging to
igure 12. Color flow volume rendering. These data were obtained in a pati
et in systole (A). Both regurgitant jet and left atrium (LA) could be manu
mages superimposed on the 3D image (B and C). The vena contracta (ar
evel of the vena contracta is visualized along with the gray-scale informatecome clinically useful. wurgical or transcatheter interventions. There has been
nterest in intraoperative application of 3D imaging as well
s intraprocedural guidance of transcatheter interventions in
he catheterization laboratory (162,163). Also, in the elec-
rophysiology laboratory, electroanatomical mapping using
lectromagnetic sensor localization has become widely
dopted for complicated procedures (164,165). Intraopera-
ive real-time 3D imaging has mostly been performed from
he epicardial surface using narrow-angled acquisition,
hich only allows the visualization of a relatively thin slice
f the heart. One disadvantage of epicardial imaging is the
ifficulty in maintaining acoustic coupling between the
ransducer and the beating heart. In addition, the use of
ide-angled acquisition in this context is limited because it
equires cropping of the data set to visualize the structure of
nterest and thus does not provide easy and immediate visual
eedback to the surgeon. Despite these difficulties, several
roups have used real-time 3D imaging of the beating heart
uring on-pump procedures to visualize suture closure of
trial septal defects in animal models (166–168).
erinatology and fetal heart. Dynamic 3D echocardiog-
aphy originally developed for the radiology and perinatol-
gy market also has been used for cardiac imaging in the
etus and sometimes in newborns. A curved ultrasound array
ith mitral stenosis depicting a 3-dimensional (3D) mitral regurgitant (MR)
aced to estimate the MR and LA volume, displayed as a surface-rendered
of the regurgitant jet is shown in two orthogonal views (D and E). The
).ent w
ally trith a motorized handle can develop 3D images of the fetus
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November 21, 2006:2053–69 3D Echocardiographyn a wide or narrow field with a rapid mechanical sweep fast
nough to stop the heart, therefore avoiding motion arti-
acts. For resolving heart motion, the mechanical sweep can
e either fast (15 or 30 frames/s, covering a narrow field of
iew over the fetal chest) or slow with realignment sweeping
cross the field with high line density. Then the temporal
ntegration is computed, realigning frames that are matched
o the phases of the cardiac cycle by correlating the position
f the major interfaces, especially on technically good
igure 13. Real-time 3-dimensional color Doppler stroke volume computa
LVOT) throughout the cardiac cycle allows accurate quantification of lef
igure 14. Real-time 3-dimensional (3D) fetal echocardiography. (A) A
ulmonary valve showing a small pulmonary annulus with no valve tissue and
low-sweep image of ventricular filling in a normal 21-week fetus.mages when the fetus does not move or the mother is not
reathing. These provide dynamic sequences at 16 to 18
rames per cycle that are measurable for cardiac volumes
ith acceptable accuracy (169,170) (Fig. 14).
This method will gradually be replaced by smaller,
arger-aperture matrix technology that requires a higher
requency than is currently available on real-time adult
ardiac 3D systems. The original work in this type of
ealignment (171,172) was followed by other methods of
Dynamic analysis of Doppler velocities in the left ventricular outflow tract
ricular stroke volume. AV  aortic valve.
image obtained in a 23-week fetus with tetralogy of Fallot and absent3D
a dilated main pulmonary artery. (B) Spatio-temporal image correlation
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3D Echocardiography November 21, 2006:2053–69chieving cardiac gating for fetal wide-field views, in-
lude navigator-type gating of the image data itself, or
sing a separate waveform derived, for instance, from an
mbilical arterial trace.
ongenital heart disease. Although it is known that
omplex anatomy can be more easily understood by 3D
avigation, most studies to date have applied this technol-
gy to relatively simple congenital diagnostic questions,
uch as atrioventricular valvular structure and atrioventric-
lar canal en-face views of atrial and ventricular septal
efects for sizing (173–175). The concept was also put forth
hat with the real-time 3D imaging, the entire examination
ight be completed rapidly using a small number of
ide-angled acquisitions, thus avoiding the need for pedi-
tric and infant sedation. Nonetheless, excellent renderings
f intraventricular anatomical abnormalities, congenital
eart valvular disease, and aortic arch and vascular abnor-
alities have been published (176,177).
Although in adult patients most attention has been
ocused on the 3D quantification of the LV volumes and
ass, in congenital heart disease the key focus has been on
erial assessment of right ventricular volume. Surgical plan-
ing and postoperative status of many patients with con-
enital heart disease rests with accurate direct quantification
f right ventricular function. Most published outcomes
tudies have involved MRI quantifications of right ventric-
lar volume and EFs, but many MRI studies have used an
versimplified approach that does not fully image the inflow
nd outflow tracts. Accordingly, a more sophisticated mul-
iplanar approach incorporating RV inflow and outflow
omponents for volume and mass quantification has been
escribed for both MRI and ultrasound applications
igure 15. Real-time 3-dimensional imaging of the right ventricle. Sub-
ostal data set shows both inlet and outflow components of the right
entricle required for accurate right ventricular volume determination. MB
moderator band; OS INF  os infundibulum or opening of the right
entricular outflow tract; LV  left ventricle;. PV  pulmonary valve; TV
tricuspid valve.168,178) (Fig. 15). CUTURE DIRECTIONS
uture advances in transducer and computer technology will
llow wider angle acquisition and color flow imaging to be
ompleted in a single cardiac cycle, which will shorten data
cquisition time and eliminate stitching artifacts. The trans-
ucers will have a smaller footprint and weight with higher
patial and temporal resolution. In addition, transducers
apable of 2D imaging only will be gradually phased out and
eplaced by new probes that will be versatile in their
apability of imaging in different modes, including 2D, 3D,
nd color and tissue Doppler. With these multitasking
ransducers, it may be possible to significantly reduce the
umber of steps required to complete an echocardiographic
xamination, and thus reduce the time required for the test.
or example, the standard 2D views could theoretically be
btained from a single volumetric data set and used for
iagnostic purposes, assuming that both spatial and tempo-
al resolution are sufficiently high. Significant improvements
rom the current state of the art are needed in the temporal
esolution as well as in the spatial resolution in the far field.
e also anticipate that the quantification of all cardiac
hambers, including flow dynamics, will be performed on
he imaging system in an increasingly automated fashion,
hus gradually eliminating the need for off-line analysis.
his is of crucial importance, in particular in the interven-
ional settings of the catheterization laboratory and the
perating room, where immediate visual and quantitative
eedback is important. For the purposes of interpretation
nd storage, it is vital that the 3D data sets are incorporated
nto digital information systems with full rendering and
uantification capabilities.
ONCLUSIONS
n summary, in the coming years, we anticipate that
eal-time 3D imaging will continue to be integrated into the
outine echocardiographic examination. Presently there is
ufficient evidence to prove that 3D imaging is superior to
he traditional 2D techniques and should be routinely used
n 2 clinical scenarios: 1) quantification of LV volume, EF,
nd mass; and 2) quantification of the mitral valve area in
itral stenosis. Future clinical applications of this technol-
gy are likely to include stress testing with real-time
olumetric or simultaneous multiplane imaging from a
ingle transducer position. Volumetric assessment of ven-
ricular asynchrony will be used as an additional tool to
uide resynchronization therapy. Also, miniaturization of
he matrix-array transducer technology will enable both the
cquisition of real-time 3D transesophageal images and the
evelopment of small-footprint probes suited for pediatric
ransthoracic and fetal imaging.
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